Down-regulation of beta 3-integrin inhibits bone metastasis of small cell lung cancer

Bone is one of the most frequent targets of small cell lung cancer (SCLC) metastasis, but the molecular mechanism remains unclear. beta 3-integrin plays an important role in invasion of various kinds of tumors. Yet, its role in bone-metastasis of SCLC is still unknown. In this study, we first examin...

Full description

Saved in:
Bibliographic Details
Published in:Molecular biology reports 2012-03, Vol.39 (3), p.3029-3035
Main Authors: Li, Na, Zhang, Jian-ping, Guo, Shan, Min, Jie, Liu, Li-li, Su, Hai-chuan, Feng, Ying-ming, Zhang, He-long
Format: Article
Language:English
Subjects:
Apoptosis
Bone cancer
Bone tumors
Cell adhesion
Cell migration
Immunofluorescence
Lung cancer
Metastases
Molecular modelling
mRNA
Polymerase chain reaction
siRNA
Tumor cells
Tumors
Western blotting
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Bone is one of the most frequent targets of small cell lung cancer (SCLC) metastasis, but the molecular mechanism remains unclear. beta 3-integrin plays an important role in invasion of various kinds of tumors. Yet, its role in bone-metastasis of SCLC is still unknown. In this study, we first examined the expression of beta 3-integrin in SBC-5 and SBC-3 cells by real-time PCR, western blot and immunofluorescence. We found that, compared to none bone-metastatic SBC-3 cells, beta 3-integrin was highly expressed in SBC-5 cells, a specific bone-metastatic SCLC cells line characterized in our previous study. We next constructed beta 3-integrin siRNA and transfected SBC-5 cell line, and found that beta 3-integrin siRNA significantly down-regulated the beta 3-integrin mRNA level and protein expression in SBC-5 cell line. We further found that inhibition of beta 3-integrin significantly reduced tumor cell proliferation and induced apoptosis. In addition, the beta 3-integrin down-regulated cells presented significant decrease in cell adhesion, migration and invasion activity. Our results suggest the beta 3-integrin has an essential effect on tumor cell proliferation and progression, and may be a potential therapeutic target for the prevention of skeletal metastases of lung cancer.
ISSN:0301-4851
1573-4978
DOI:10.1007/s11033-011-1065-y